The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired ...

ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves (MHV)—and the one designed in their own lab appears to outperform the others.